ArticleFrontiers in genetics2025
Identification of key genes associated with infertile endometriosis based on bioinformatic analysis.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- GREB1 as a Context-Dependent Molecular Switch in Endometrial Estrogen-Progesterone Crosstalk: From Physiological Receptivity to Endometriosis Pathogenesis-A Narrative Review.International journal of women's health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endometriosis is a common disease among women of childbearing age. However, the molecular mechanism behind it is still unknown. Therefore, new biomarkers and therapeutic targets are needed to improve the diagnosis and treatment of infertile women. Methods: Microarray datasets GSE7305, GSE7307, and GSE51981 were downloaded from the Gene Expression Omnibus database to identify differentially expressed genes (DEGs) between control and endometriosis. The STRING database and Cytoscape software constructed protein-protein interaction and hub gene networks. At the same time, the three data sets were screened for co-differentially expressed genes related to mitosis. Subsequently, we identified mitosis-related hub genes (MRHGs) associated with both mitosis-related genes and hub genes. Next, enrichment analysis for target genes was performed by Gene Ontology (GO) annotation and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and the mRNA-miRNA network was constructed. Finally, GSE25628 and GSE6364 were used to verify the expression of MRHGs individually, while GSE120103 was employed to ascertain the influence of mitosis-related genes on female fertility. Results: A total of 93 DEGs were identified in the endometriosis datasets. Then, we placed 11 potential mitosis-related downregulated hub genes, among which eight showed good diagnostic properties of endometriosis, and two showed good diagnostic properties of infertile endometriosis. The main enriched GO functions revealed that the cell cycle mitotic pathway may be the critical pathway in endometriosis. Meanwhile, mRNA-miRNA interaction networks were constructed by choosing co-expressed mRNAs and miRNAs. Furthermore, cordycepin showed high drug-targeting relevance in infertile endometriosis. Conclusion: We identified eight mitosis-related hub genes as potential biomarkers for diagnosing and treating endometriosis. CENPE and CCNA2 might be associated with infertile endometriosis by affecting the endometrial secretory phase transition. In addition, cordycepin may be a potential clinical treatment for people with infertility-related endometriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.